Our R&D Pipeline

OUR SCIENTIFIC ADVISORY BOARD

Dr. Mark Stacy,
Duke University Medical Center, Durham, NC - Co-Chair

Dr. Oscar Gershanik,
Scientific Director, Fundacion Favaloro, Buenos Aires, Argentina

Dr. Daniel Weintraub,
University of Pennsylvania, Philadelphia, PA

Dr. Anette Schrag,
Royal Free & University College Medical School, London, UK

OVERVIEW OUR BUSINESS OUR HISTORY OUR LOCATIONS DEVELOPMENT FACILITIES OUR MANAGEMENT TEAM OUR BOARD OF DIRECTORS OUR INVESTORS OUR EMPLOYEES WHAT'S NEW OVERVIEW PARTNERING WITH OSMOTICA OUT-LICENSING OPPORTUNITIES IN-LICENSING INTERESTS PROJECT MANAGEMENT OVERVIEW OSMODEX FAMILY OTHER TECHNOLOGIES INTELLECTUAL PROPERTY R&D STRATEGY NEUROLOGY PIPELINE PARTNERED PIPELINE TECHNOLOGY PIPELINE SCIENTIFIC ADVISORY BOARD LICENSED PRODUCTS APPROVED IN U.S. APPROVED IN OTHER COUNTRIES CONTACT US

Version 8 October 6, 2009 | Copyright © 2009 Osmotica Pharmaceutical Corp., All rights reserved. | Terms and Conditions